Skip to menu Skip to content Skip to footer

A randomised placebo-controlled crossover trial of micronised resveratrol as a treatment for Friedreich ataxia (2019-2022)

Experts

Associate Professor John O'Sullivan

ATH - Associate Professor
UQ Centre for Clinical Research
Faculty of Medicine
John O'Sullivan
John O'Sullivan